Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd Price : 0.6636 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 0.64 | 0.64 | 0.6008 | 0.6078 | 4.000M |
| Oct 13, 2026 | 0.66 | 0.6731 | 0.64 | 0.646 | 3.657M |
| Oct 12, 2026 | 0.71 | 0.717 | 0.6625 | 0.6733 | 2.825M |
| Oct 09, 2026 | 0.70 | 0.7383 | 0.6907 | 0.7212 | 2.767M |
| Oct 08, 2026 | 0.7398 | 0.74 | 0.67 | 0.7004 | 10.44M |
| Oct 07, 2026 | 0.8037 | 0.82 | 0.7250 | 0.7286 | 9.468M |
| Oct 06, 2026 | 0.8522 | 0.8538 | 0.8003 | 0.8064 | 5.049M |
| Oct 05, 2026 | 0.8199 | 0.8449 | 0.7902 | 0.8392 | 5.426M |
| Oct 02, 2026 | 0.8348 | 0.8442 | 0.77 | 0.8221 | 7.129M |
| Oct 01, 2026 | 0.8653 | 0.898 | 0.8057 | 0.8165 | 5.460M |
| Sep 30, 2026 | 0.8551 | 0.8792 | 0.8208 | 0.8701 | 8.386M |
| Sep 29, 2026 | 0.9209 | 0.9338 | 0.7738 | 0.8501 | 31.29M |
| Sep 28, 2026 | 0.9761 | 1.01 | 0.94 | 0.95 | 11.01M |
| Sep 25, 2026 | 0.9208 | 0.9469 | 0.901 | 0.9342 | 3.489M |
| Sep 24, 2026 | 0.95 | 0.97 | 0.89 | 0.9133 | 6.000M |
| Sep 23, 2026 | 0.95 | 0.965 | 0.9113 | 0.9231 | 6.910M |
| Sep 22, 2026 | 1.01 | 1.01 | 0.91 | 0.964 | 8.439M |
| Sep 21, 2026 | 0.8349 | 1.05 | 0.82 | 1.02 | 15.01M |
| Sep 18, 2026 | 0.7556 | 0.7863 | 0.7306 | 0.7553 | 6.278M |
| Sep 17, 2026 | 0.82 | 0.8344 | 0.73 | 0.7462 | 5.843M |
| Sep 16, 2026 | 0.83 | 0.84 | 0.8007 | 0.8053 | 3.594M |
| Sep 15, 2026 | 0.8812 | 0.893 | 0.82 | 0.83 | 4.235M |
| Sep 14, 2026 | 0.82 | 0.9361 | 0.8021 | 0.8918 | 3.802M |
| Sep 11, 2026 | 0.7901 | 0.8174 | 0.7711 | 0.7855 | 4.385M |
| Sep 10, 2026 | 0.7822 | 0.8151 | 0.7703 | 0.7759 | 1.901M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.69 |
| Amgen, Inc. | 434.01 |
| Anika Therapeutics, Inc. | 20.71 |
| BioCryst Pharmaceuticals, Inc. | 8.015 |
| Imunon, Inc. | 1.05 |
Price Related Metrics
| PS Ratio | 3.076 |
| Price to Book Value | 1.080 |
| Earnings Yield | -56.21% |
| Market Cap | 195.60M |